Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108851-108900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03543098
STaR Trial: Multiple Ligament Knee Injuries
NAActive, not recruiting
690 participants
Started: Jul 31, 2018 · Completed: Jun 30, 2027
2 conditions31 sponsors1 location
NCT03504956
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
NARecruiting
150 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03504241
Tolerance by Engaging Antigen During Cellular Homeostasis
PHASE1Active, not recruiting
8 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2029
3 conditions4 sponsors1 location
NCT03538639
Vascular Disease Discovery Protocol
N/ARecruiting
1,000 participants
Started: Jul 30, 2018 · Completed: May 15, 2037
3 conditions1 sponsor1 location
NCT03412812
A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases
NAActive, not recruiting
13 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04194138
Complex Adult Deformity Surgery (CADS)
N/ARecruiting
500 participants
Started: Jul 30, 2018 · Completed: Jul 31, 2032
4 conditions4 sponsors19 locations
NCT03854071
Development of Novel Physiological CMR Methods in Health and Disease
NARecruiting
135 participants
Started: Jul 30, 2018 · Completed: Jan 1, 2031
4 conditions1 sponsor1 location
NCT04191551
The GAstric Precancerous Conditions Study
N/ARecruiting
600 participants
Started: Jul 30, 2018 · Completed: Jun 30, 2028
4 conditions1 sponsor1 location
NCT03522064
Bipolar Androgen Therapy + Carboplatin in mCRPC
PHASE2Recruiting
30 participants
Started: Jul 30, 2018 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT04862117
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
NAActive, not recruiting
14 participants
Started: Jul 28, 2018 · Completed: Dec 8, 2026
1 condition1 sponsor4 locations
NCT02418832
Testis Needle Aspiration of Sperm in Men With Azoospermia
NARecruiting
150 participants
Started: Jul 28, 2018 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT03168516
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
PHASE3Active, not recruiting
1,065 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor32 locations
NCT03630289
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
NAActive, not recruiting
12 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT03716167
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
NARecruiting
20 participants
Started: Jul 27, 2018 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT03502668
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Jul 27, 2018 · Completed: Dec 1, 2025
1 condition1 sponsor29 locations
NCT03607422
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
PHASE3Active, not recruiting
912 participants
Started: Jul 27, 2018 · Completed: Nov 4, 2025
1 condition1 sponsor196 locations
NCT03568058
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
PHASE1Active, not recruiting
30 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03568630
Blood Markers of Early Pancreas Cancer
N/ARecruiting
1,250 participants
Started: Jul 26, 2018 · Completed: Jul 31, 2028
6 conditions4 sponsors1 location
NCT03908788
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
NAActive, not recruiting
130 participants
Started: Jul 26, 2018 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
PHASE1Active, not recruiting
10 participants
Started: Jul 26, 2018 · Completed: Jul 26, 2039
9 conditions1 sponsor1 location
NCT03589846
Muscle Stimulation During DISE
NAEnrolling by invitation
60 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03561740
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
PHASE3Recruiting
794 participants
Started: Jul 25, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03597165
Incidental Genomics
NAActive, not recruiting
289 participants
Started: Jul 25, 2018 · Completed: Oct 1, 2027
1 condition1 sponsor3 locations
NCT03285789
Dyslexics' Visual Attention Field
NAActive, not recruiting
1,460 participants
Started: Jul 25, 2018 · Completed: Oct 21, 2026
1 condition1 sponsor1 location
NCT03336606
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
PHASE1Active, not recruiting
35 participants
Started: Jul 25, 2018 · Completed: Dec 1, 2026
5 conditions3 sponsors1 location
NCT03654131
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
PHASE2Active, not recruiting
100 participants
Started: Jul 25, 2018 · Completed: Dec 3, 2029
2 conditions1 sponsor1 location
NCT03301038
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
PHASE2Recruiting
60 participants
Started: Jul 25, 2018 · Completed: Dec 31, 2030
6 conditions2 sponsors1 location
NCT03593720
Glans Size in Hypospadias Compared to Normal
N/AEnrolling by invitation
90 participants
Started: Jul 25, 2018 · Completed: Dec 29, 2025
2 conditions1 sponsor1 location
NCT03143322
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NAActive, not recruiting
168 participants
Started: Jul 24, 2018 · Completed: Jul 22, 2027
4 conditions1 sponsor28 locations
NCT03480776
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
PHASE2Active, not recruiting
117 participants
Started: Jul 24, 2018 · Completed: Sep 15, 2026
1 condition2 sponsors17 locations
NCT03389100
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
PHASE2Enrolling by invitation
600 participants
Started: Jul 24, 2018 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT03573700
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Jul 24, 2018 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT03595917
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
PHASE1Recruiting
40 participants
Started: Jul 24, 2018 · Completed: Nov 1, 2026
3 conditions2 sponsors4 locations
NCT03127904
Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial
NARecruiting
120 participants
Started: Jul 24, 2018 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03388593
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
PHASE3Recruiting
1,600 participants
Started: Jul 23, 2018 · Completed: Feb 28, 2026
1 condition1 sponsor65 locations
NCT03400215
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer
NARecruiting
135 participants
Started: Jul 23, 2018 · Completed: Apr 17, 2025
1 condition1 sponsor1 location
NCT03792867
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NAActive, not recruiting
5 participants
Started: Jul 23, 2018 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT06381232
Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population
N/ARecruiting
20,000 participants
Started: Jul 23, 2018 · Completed: Jul 23, 2028
2 conditions1 sponsor1 location
NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
PHASE2Active, not recruiting
63 participants
Started: Jul 23, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor34 locations
NCT03286868
Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense
NARecruiting
60 participants
Started: Jul 23, 2018 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03686748
Two Point Discrimination
EARLY_PHASE1Active, not recruiting
60 participants
Started: Jul 21, 2018 · Completed: Jul 16, 2027
6 conditions1 sponsor1 location
NCT03566797
Secondary Sclerosis Cholangitis Prospective
N/ARecruiting
380 participants
Started: Jul 20, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03439735
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
PHASE2Active, not recruiting
45 participants
Started: Jul 20, 2018 · Completed: Nov 1, 2026
1 condition3 sponsors1 location
NCT03237780
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
PHASE2Active, not recruiting
72 participants
Started: Jul 20, 2018 · Completed: Jun 30, 2027
24 conditions1 sponsor21 locations
NCT03354390
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
PHASE1Active, not recruiting
17 participants
Started: Jul 20, 2018 · Completed: Mar 3, 2026
1 condition2 sponsors1 location
NCT03503630
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
PHASE2Active, not recruiting
44 participants
Started: Jul 20, 2018 · Completed: Jul 2, 2024
1 condition3 sponsors3 locations
NCT03494322
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
PHASE2Active, not recruiting
130 participants
Started: Jul 20, 2018 · Completed: Oct 31, 2024
2 conditions2 sponsors1 location
NCT03521154
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)
PHASE3Active, not recruiting
216 participants
Started: Jul 19, 2018 · Completed: Apr 13, 2027
1 condition1 sponsor118 locations
NCT03505762
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
PHASE2Active, not recruiting
80 participants
Started: Jul 19, 2018 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT03727633
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
PHASE2Recruiting
53 participants
Started: Jul 19, 2018 · Completed: Jan 18, 2026
1 condition2 sponsors4 locations